论文部分内容阅读
AIM: The co-administration of dexrazoxane (DEX) with each dose of doxorubicin (DOX) is an efficient strategy to relieve DOXinduced cardiotoxicity.However, the mechanisms underlying the cardioprotective effect of DEX have not been well elucidated.